243 related articles for article (PubMed ID: 2692641)
1. Is there a relationship between serotonin receptor subtypes and selectivity of response in specific psychiatric illnesses?
Montgomery SA; Fineberg N
Br J Psychiatry Suppl; 1989 Dec; (8):63-9. PubMed ID: 2692641
[TBL] [Abstract][Full Text] [Related]
2. Role of serotonin in therapy of depression and related disorders.
Fuller RW
J Clin Psychiatry; 1991 May; 52 Suppl():52-7. PubMed ID: 1674251
[TBL] [Abstract][Full Text] [Related]
3. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
Moulignier A
Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
[TBL] [Abstract][Full Text] [Related]
4. Developments in 5-hydroxytryptamine receptor pharmacology in migraine.
Peroutka SJ
Neurol Clin; 1990 Nov; 8(4):829-39. PubMed ID: 2259314
[TBL] [Abstract][Full Text] [Related]
5. Phosphoinositide system-linked serotonin receptor subtypes and their pharmacological properties and clinical correlates.
Pandey SC; Davis JM; Pandey GN
J Psychiatry Neurosci; 1995 May; 20(3):215-25. PubMed ID: 7786883
[TBL] [Abstract][Full Text] [Related]
6. Serotonin receptor subtypes: implications for psychopharmacology.
Cowen PJ
Br J Psychiatry Suppl; 1991 Sep; (12):7-14. PubMed ID: 1840764
[TBL] [Abstract][Full Text] [Related]
7. Serotonin and psychiatric disorders. A key to new therapeutic approaches.
Costall B; Naylor RJ
Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395
[TBL] [Abstract][Full Text] [Related]
8. Studies on the neuroendocrine role of serotonin.
Jørgensen HS
Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
[TBL] [Abstract][Full Text] [Related]
9. Role of serotonin in memory impairment.
Buhot MC; Martin S; Segu L
Ann Med; 2000 Apr; 32(3):210-21. PubMed ID: 10821328
[TBL] [Abstract][Full Text] [Related]
10. [Neuroleptics and serotonin].
Hery F; Hamon M
Encephale; 1993; 19(5):525-32. PubMed ID: 7905821
[TBL] [Abstract][Full Text] [Related]
11. 5-Hydroxytryptamine-receptor subtypes.
Brodde OE
Clin Physiol Biochem; 1990; 8 Suppl 3():19-27. PubMed ID: 2132174
[TBL] [Abstract][Full Text] [Related]
12. Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets.
Terry AV; Buccafusco JJ; Wilson C
Behav Brain Res; 2008 Dec; 195(1):30-8. PubMed ID: 18241938
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
Hamel E; Robert JP; Young AR; MacKenzie ET
J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
[TBL] [Abstract][Full Text] [Related]
14. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
Stratford CA; Tan GL; Hamblin MW; Ciaranello RD
Mol Pharmacol; 1988 Oct; 34(4):527-36. PubMed ID: 3139989
[TBL] [Abstract][Full Text] [Related]
15. [Serotonin receptor subtypes. Considerations on their physiological role and therapeutic prospects].
Di Renzo G; Marino A
Clin Ter; 1990 Apr; 133(1):3-7. PubMed ID: 2140742
[TBL] [Abstract][Full Text] [Related]
16. 5-HT receptors mediating external carotid vasoconstriction in vagosympathectomized dogs.
Villalón CM; Centurión D; Sánchez-López A; De Vries P; Saxena P
Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1057-67. PubMed ID: 11216445
[TBL] [Abstract][Full Text] [Related]
17. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
de Boer SF; Koolhaas JM
Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
[TBL] [Abstract][Full Text] [Related]
18. 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
Massot O; Rousselle JC; Fillion MP; Grimaldi B; Cloëz-Tayarani I; Fugelli A; Prudhomme N; Seguin L; Rousseau B; Plantefol M; Hen R; Fillion G
Mol Pharmacol; 1996 Oct; 50(4):752-62. PubMed ID: 8863819
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic mechanisms in aggression.
Olivier B
Novartis Found Symp; 2005; 268():171-83; discussion 183-9, 242-53. PubMed ID: 16206880
[TBL] [Abstract][Full Text] [Related]
20. [Recent advances in neuropsychopharmacology of the central serotonin receptor].
Yamawaki S; Hayakawa H
Yakubutsu Seishin Kodo; 1992 Apr; 12(2):43-54. PubMed ID: 1441762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
